DEF 14AThe Ballot
Candel Therapeutics, Inc. files DEF 14A
Filed Apr 29, 2026 · 2mo ago · Accession 0001193125-26-191506
Plain English
Proxy statement — executive pay, board nominees, and shareholder votes.
Read the source below for the full document.
Filing details
- Company
- Candel Therapeutics, Inc.
- Ticker
- CADL
- CIK
- 1841387
- Form type
- DEF 14A
- Filing date
- Apr 29, 2026
- Report date
- Jun 23, 2026
- Document
- cadl-20260429.htm
- Size
- 4.8 MB